Oakley, Gerard

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Chen, P., Nirula, A., Heller, B., Gottlieb, R. L., Boscia, J., Morris, J., Huhn, G., Cardona, J., Mocherla, B., Stosor, V., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,282

A foundation model for clinical-grade computational pathology and rare cancers detection

Vorontsov, E., Bozkurt, A., Casson, A., Shaikovski, G., Zelechowski, M., Severson, K., Zimmermann, E., Hall, J., Tenenholtz, N., Fusi, N., et al. (2024) · Nature Medicine

AI in cancer detectionArtificial Intelligence in Healthcare and Education

Cited by 572

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

Goldman, J. W., Mazieres, J., Barlesi, F., Dragnev, K. H., Koczywas, M., Göskel, T., Cortot, A. B., Girard, N., Wesseler, C., Bischoff, H., et al. (2020) · Frontiers in Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 52

PRISM: A Multi-Modal Generative Foundation Model for Slide-Level Histopathology

Shaikovski, G., Casson, A., Severson, K., Zimmermann, E., Wang, Y. K., Kunz, J. D., Retamero, J. A., Oakley, G., Klimstra, D., Kanan, C., et al. (2024) · arXiv

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 22